GAMMAGARD LIQUID is a ready-to-use liquid medicine that is given in a vein (intravenously) to treat multifocal motor neuropathy (MMN) in adults.
GAMMAGARD LIQUID was studied in 44 adult patients over the course of 60 weeks. Patients rotated between taking placebo (no medicine) and GAMMAGARD LIQUID. In the study, patients taking GAMMAGARD LIQUID showed:
Improved grip strength
Improvement in disability
GAMMAGARD LIQUID was also shown to maintain dexterity in the hands.
It’s important to talk to your healthcare provider about what to expect with administration of GAMMAGARD LIQUID IVIG treatment. Your doctor, nurse, or other healthcare professional can help you prepare for treatment and tell you what can be done to manage possible side effects.
Your experience with MMN is personal, so this discussion guide is all about you. We’ll ask questions to help you have a discussion with your doctor about where you are now—so you can start working toward where you want to be.